LUCY LETBY CASE ERUPTS AGAIN AS EXPERTS CHALLENGE KEY INSULIN EVIDENCE

LONDON — One of Britain’s most closely watched criminal cases is facing renewed scrutiny as fresh medical analysis raises questions about one of the most important pieces of evidence used against former neonatal nurse Lucy Letby.

Letby remains behind bars under whole-life orders after being convicted of murdering seven babies and attempting to murder seven others at the Countess of Chester Hospital between 2015 and 2016.

But the case has entered another extraordinary chapter.

New expert analysis has challenged the interpretation of the insulin evidence involving two babies, arguing that alternative medical explanations deserved greater consideration.

The developments have become a major focus of Letby’s continuing challenge to her convictions.

THE INSULIN EVIDENCE AT THE CENTER OF THE STORM

During Letby’s trial, prosecutors argued that unusually high insulin levels found in two babies could not be explained naturally and were evidence that the infants had deliberately been given insulin.

That evidence became a central part of the prosecution’s case.

But independent experts have since questioned whether the medical data necessarily proved deliberate insulin poisoning.

A widely reported 100-page expert study previously concluded that aspects of the insulin evidence were inconsistent with the prosecution’s interpretation. One of its authors, Professor Geoff Chase, said there was no scientific justification for stating with certainty that the babies had been deliberately poisoned.

More recent expert analysis has continued to challenge how the evidence was presented and interpreted.

“ALTERNATIVE EXPLANATIONS” NOW UNDER THE MICROSCOPE

A newer report associated with Letby’s legal challenge argues that other possible explanations for the babies’ clinical deterioration should have received greater attention.

That does not establish that Letby did not commit the offenses for which she was convicted.

Instead, it raises a narrower but potentially crucial question:

Did the original evidence allow the jury to be certain that insulin had been deliberately administered?

That distinction could become extremely important if the Criminal Cases Review Commission determines that aspects of the original convictions require further examination.

WHY THE BLOOD TESTS MATTER SO MUCH

The prosecution’s case relied heavily on laboratory findings involving insulin and C-peptide, a hormone produced naturally alongside insulin.

At trial, prosecutors argued that the pattern was consistent with the administration of insulin from outside the body.

Critics of the original interpretation say the evidence was more complicated than the jury was led to believe and that modern scientific understanding should be considered.

A 2026 analysis has again raised concerns about the reliability and interpretation of the insulin evidence used to support the convictions.

The debate is now essentially about whether the laboratory evidence was definitive — or whether it left room for reasonable alternative explanations.

THE CCRC IS NOW A CRITICAL PART OF THE STORY

Letby’s legal team has taken its case to the Criminal Cases Review Commission, the independent body responsible for investigating potential miscarriages of justice.

The CCRC has received extensive expert material concerning the convictions, although many of the underlying reports are not publicly available.

That means the public picture remains incomplete.

Experts may be challenging important aspects of the prosecution’s case, but the CCRC has not announced that Letby’s convictions are unsafe.

And until a court changes the verdicts, those convictions remain legally valid.

A SECOND BATTLE: WHAT WAS HAPPENING INSIDE THE HOSPITAL?

The insulin controversy is unfolding alongside a much broader examination of the Countess of Chester Hospital.

The Thirlwall Inquiry was established to examine what happened at the hospital, including how concerns about the babies’ collapses and deaths were handled and what lessons should be learned.

The inquiry has finished hearing evidence and is now preparing its final report. Its official website said in August that publication would not take place until after Parliament’s summer recess, with a further update to come.

The inquiry is separate from the criminal appeal process.

Its findings cannot simply overturn Letby’s convictions.

But they could provide important context about hospital management, staffing, clinical decision-making and how concerns were handled before and during the period covered by the criminal case.

THE CASE HAS BECOME A BATTLE OVER SCIENCE

What makes the current controversy so unusual is that the debate is not simply about witness credibility.

It is increasingly about medical interpretation.

How should insulin levels in premature and critically ill infants be interpreted?

Were the laboratory results conclusive?

Could natural medical processes have produced some of the findings?

Were alternative explanations adequately explored?

And, perhaps most importantly, did the jury receive the full scientific picture?

Those questions are now being examined years after the original investigation.

EXPERTS ARE NOT THE SAME AS A COURT

The growing criticism has generated headlines suggesting that Letby’s convictions have been “disproved.”

That goes further than the evidence currently supports.

Some experts have strongly challenged the scientific reasoning behind parts of the prosecution case.

But those opinions do not themselves overturn a criminal conviction.

Letby remains convicted.

The CCRC has not ruled that her convictions are unsafe.

And there has been no judicial finding that the insulin evidence was fabricated or that Letby was wrongly convicted.

What has changed is that the evidence is being debated again at a level that could potentially influence the next stage of her legal battle.

WHAT HAPPENS NEXT?

The CCRC must determine whether there is sufficient reason to refer Letby’s case back to the courts.

If it does, an appeal could provide another opportunity to examine the disputed evidence.

If it does not, Letby’s convictions would remain in place unless another legal route becomes available.

Meanwhile, the Thirlwall Inquiry is expected to provide its own assessment of the institutional failures and events surrounding the neonatal unit.

Two separate processes are therefore moving toward potentially significant moments.

One concerns whether Letby’s convictions should be reconsidered.

The other concerns what went wrong inside the hospital.

A CASE THAT REFUSES TO DISAPPEAR

Lucy Letby’s name became synonymous with one of Britain’s most disturbing criminal cases.

Now, years after her conviction, the case is once again being examined through a different lens — not simply through the actions attributed to Letby, but through the science, statistics and hospital evidence used to build the prosecution’s narrative.

The insulin evidence sits at the heart of that debate.

For Letby’s supporters, the new analysis represents a potentially devastating challenge to the original case.

For prosecutors and those who continue to support the convictions, the verdicts remain the result of a lengthy trial in which jurors considered extensive evidence.

The legal position is unchanged for now:

Lucy Letby remains convicted.

But as experts continue to challenge parts of the medical evidence and the CCRC reviews the case, one question refuses to disappear:

Could the science that helped convict Lucy Letby ultimately become the evidence that forces Britain’s justice system to look at her case all over again?